Aphria Inc (APHA)
$5.80 0.09 (1.58%)
12:36 EST APHA Stock Quote Delayed 15 Minutes
Previous Close $5.71
Market Cap -
PE Ratio -
Volume (Avg. Vol.) 5.93M
Day's Range 5.54 - 5.98
52-Week Range 3.76 - 10.95
Dividend & Yield N/A (N/A)
APHA Stock Predictions, Articles, and Aphria Inc News
- From InvestorPlace
- From the Web
Despite the fact that APHA has posted two straight profitable quarters, Aphria stock has been hit hard this week as Cannabis 2.0 stumbles.
It’s unlikely to be the next Netflix or Microsoft, but Canopy Growth stock has made the case for today’s investors to take a nibble
Aphria is still losing money despite management guidance. Free cash flow was negative in the latest quarter and its cash balance fell fruther despite management's rosy outlook.
Given its profits amid an industry slowdown, Aphria stock should move higher as legalization 2.0 draws investors, consumers to APHA.
By Thomas Niel
But does this make APHA stock a buy today? Perhaps. Analyst consensus projects positive earnings-per-share for Aphria stock in 2020 and 2021. Meanwhile, the above-mentioned peers will remain unprofitable. The bigger names dominate the headlines. But under-the-radar Aphria may be the best "pot stock" buy.
By David Moadel
Solid financing and the implementation of Cannabis 2.0 will drive Aphria's growth in 2020's first half.
Pot stocks had a dark and depressing 2019, but 2020 could prove to a be much brighter year for this beaten-up group.
It’s been horrific for cannabis stocks. But Aphria stock is presenting some interesting opportunities. Here’s a look at this standout company.
With arguably most of the bad news baked into cannabis stocks, it’s time for the differentiators like APHA stock to step forward.
The outlook for cannabis stocks remains challenging. But if anyone can turn it around in 2020, it could well be Aphria.
Like other Canadian cannabis stocks, APHA stock has taken a beating in recent months as revenue growth has fallen short of expectations. However, there are at least five reasons why Aphria shares could be headed higher soon.
Hexo stock is showing improvement on the charts, but we need a significant improvement given the lacking fundamentals and industry disdain.
Aphria executives believe oversupply fears are overstated. If they're right, APHA stock can soar.
Marijuana legalization in the US looks unlikely in the near-term, but investors should be keeping an eye on these 4 marijuana stocks for the future of the market.
Canadian cannabis producer Aphria hit an all-time low of $3.76 Nov. 19. Since then, Aphria stock has recovered nicely. Is that the bottom?
With some recent bullish moves, Aurora Cannabis stock looks interesting as a contrarian trade. However, it has much to prove before anyone can offer a confident recommendation.
Aphria stock has tremendous long-term upside potential, but near-term headwinds will likely keep shares depressed for now.
Despite the steep discount in Tilray stock, this remains a name to avoid because neither the fundamentals nor technicals imply a positive trajectory.
From The Motley Fool
From Talk Markets
From The Motley Fool
Navellier RatingsPowered by Portfolio Grader